arg1 fitc (R&D Systems)
93
Structured Review
R&D Systems
arg1 fitc
Arg1 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 41 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arg1+fitc/Human%2FMouse+Arginase+1%2FARG1+Fluorescein-conjugated+Antibody/bio_rxiv__2025__11__12__688098-179-80-82
Average 93 stars, based on 41 article reviews
Arg1 Fitc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 41 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/arg1+fitc/Human%2FMouse+Arginase+1%2FARG1+Fluorescein-conjugated+Antibody/bio_rxiv__2025__11__12__688098-179-80-82
Average 93 stars, based on 41 article reviews
arg1 fitc - by Bioz Stars,
2026-10
93/100 stars
Images
Related Articles
Single Cell:Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer Article Snippet: After single-cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single-cell suspension was stained according to standard protocols with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer. Article Snippet: After single- cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single- cell suspension was stained according to standard protocols with the following antibodies: CD3- PE- 594 (#100246, BioLegend), CD45- Pacific Blue (#103126, BioLegend), CD4- APCCy7 (#100526, BioLegend), CD8- PE- Cy7 (#100721, BioLegend), CD278- PE (#117406, BioLegend), CD25BUV395 (#564022, BD Biosciences), PD1- BV- 505 (#135220, BioLegend), CD62L- FITC (#35- 0621- U500, Thermo Fisher Scientific), CD44- BV- 711 (#103057, BioLegend), TIM3- APC (#134007, BioLegend), FoxP3- PerCP- Cy5.5 (#45- 5773- 82, Invitrogen), GR1- BV- 711 (#106443, BioLegend), CD11b- BV- 650 (#101239, BioLegend), CD11c- BV- 785 (#117335, BioLegend), F4/80- APC (#204801- U100, Tonbo), PDL1- PE- Dazzle- 594 (#124323, BioLegend), CD86- APC- Cy7 (#105030, BioLegend), MCHII- PE- Cy7 (#107629, BioLegend), CD80- BV- 605 (#104729, BioLegend), CD68- PerCP- Cy5.5 (#137009, BioLegend), iNOS- PE (#125920- 80, Invitrogen), Article Title: EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression Article Snippet: .. Single-cell suspension was stained as described previously ( ) with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Suspension:Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer Article Snippet: After single-cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single-cell suspension was stained according to standard protocols with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer. Article Snippet: After single- cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single- cell suspension was stained according to standard protocols with the following antibodies: CD3- PE- 594 (#100246, BioLegend), CD45- Pacific Blue (#103126, BioLegend), CD4- APCCy7 (#100526, BioLegend), CD8- PE- Cy7 (#100721, BioLegend), CD278- PE (#117406, BioLegend), CD25BUV395 (#564022, BD Biosciences), PD1- BV- 505 (#135220, BioLegend), CD62L- FITC (#35- 0621- U500, Thermo Fisher Scientific), CD44- BV- 711 (#103057, BioLegend), TIM3- APC (#134007, BioLegend), FoxP3- PerCP- Cy5.5 (#45- 5773- 82, Invitrogen), GR1- BV- 711 (#106443, BioLegend), CD11b- BV- 650 (#101239, BioLegend), CD11c- BV- 785 (#117335, BioLegend), F4/80- APC (#204801- U100, Tonbo), PDL1- PE- Dazzle- 594 (#124323, BioLegend), CD86- APC- Cy7 (#105030, BioLegend), MCHII- PE- Cy7 (#107629, BioLegend), CD80- BV- 605 (#104729, BioLegend), CD68- PerCP- Cy5.5 (#137009, BioLegend), iNOS- PE (#125920- 80, Invitrogen), Article Title: EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression Article Snippet: .. Single-cell suspension was stained as described previously ( ) with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Staining:Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer Article Snippet: After single-cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single-cell suspension was stained according to standard protocols with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer. Article Snippet: After single- cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single- cell suspension was stained according to standard protocols with the following antibodies: CD3- PE- 594 (#100246, BioLegend), CD45- Pacific Blue (#103126, BioLegend), CD4- APCCy7 (#100526, BioLegend), CD8- PE- Cy7 (#100721, BioLegend), CD278- PE (#117406, BioLegend), CD25BUV395 (#564022, BD Biosciences), PD1- BV- 505 (#135220, BioLegend), CD62L- FITC (#35- 0621- U500, Thermo Fisher Scientific), CD44- BV- 711 (#103057, BioLegend), TIM3- APC (#134007, BioLegend), FoxP3- PerCP- Cy5.5 (#45- 5773- 82, Invitrogen), GR1- BV- 711 (#106443, BioLegend), CD11b- BV- 650 (#101239, BioLegend), CD11c- BV- 785 (#117335, BioLegend), F4/80- APC (#204801- U100, Tonbo), PDL1- PE- Dazzle- 594 (#124323, BioLegend), CD86- APC- Cy7 (#105030, BioLegend), MCHII- PE- Cy7 (#107629, BioLegend), CD80- BV- 605 (#104729, BioLegend), CD68- PerCP- Cy5.5 (#137009, BioLegend), iNOS- PE (#125920- 80, Invitrogen), Article Title: EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression Article Snippet: .. Single-cell suspension was stained as described previously ( ) with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Marker:Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer Article Snippet: After single-cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single-cell suspension was stained according to standard protocols with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), Article Title: EMT activates exocytotic Rabs to coordinate invasion and immunosuppression in lung cancer. Article Snippet: After single- cell suspensions were obtained, RBCs were lysed using 1 × RBC lysis buffer (BioLegend) following manufacturer instructions. .. Single- cell suspension was stained according to standard protocols with the following antibodies: CD3- PE- 594 (#100246, BioLegend), CD45- Pacific Blue (#103126, BioLegend), CD4- APCCy7 (#100526, BioLegend), CD8- PE- Cy7 (#100721, BioLegend), CD278- PE (#117406, BioLegend), CD25BUV395 (#564022, BD Biosciences), PD1- BV- 505 (#135220, BioLegend), CD62L- FITC (#35- 0621- U500, Thermo Fisher Scientific), CD44- BV- 711 (#103057, BioLegend), TIM3- APC (#134007, BioLegend), FoxP3- PerCP- Cy5.5 (#45- 5773- 82, Invitrogen), GR1- BV- 711 (#106443, BioLegend), CD11b- BV- 650 (#101239, BioLegend), CD11c- BV- 785 (#117335, BioLegend), F4/80- APC (#204801- U100, Tonbo), PDL1- PE- Dazzle- 594 (#124323, BioLegend), CD86- APC- Cy7 (#105030, BioLegend), MCHII- PE- Cy7 (#107629, BioLegend), CD80- BV- 605 (#104729, BioLegend), CD68- PerCP- Cy5.5 (#137009, BioLegend), iNOS- PE (#125920- 80, Invitrogen), Article Title: EMT activates ER-to-Golgi trafficking through upregulation of REEP2 to promote lung cancer progression Article Snippet: .. Single-cell suspension was stained as described previously ( ) with the following antibodies: CD3-PE-594 (#100246, BioLegend), CD45-Pacific Blue (#103126, BioLegend), CD4-APCCy7 (#100526, BioLegend), CD8-PE-Cy7 (#100721, BioLegend), CD278-PE (#117406, BioLegend), CD25-BUV395 (#564022, BD Biosciences), PD1-BV-505 (#135220, BioLegend), CD62L-FITC (#35-0621-U500, Thermo Fisher Scientific), CD44-BV-711 (#103057, BioLegend), TIM3-APC (#134007, BioLegend), FoxP3-PerCP-Cy5.5 (#45-5773-82, Invitrogen), GR1-BV-711 (#106443, BioLegend), CD11b-BV-650 (#101239, BioLegend), CD11c-BV-785 (#117335, BioLegend), F4/80-APC (#204801-U100, Tonbo), PDL1-PE-Dazzle-594 (#124323, BioLegend), CD86-APC-Cy7 (#105030, BioLegend), MCHII-PE-Cy7 (#107629, BioLegend), CD80-BV-605 (#104729, BioLegend), CD68-PerCP-Cy5.5 (#137009, BioLegend), iNOS-PE (#125920-80, Invitrogen), other:Article Title: p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi Article Snippet: H1299 cells stably expressing RAB6A-EGFP were plated on 35-mm glass-bottom plates (MatTek), transfected with siRNAs, formalin-fixed 72 hours later, and imaged using a Nikon A1+ confocal microscope equipped with 488-nm laser line, GaAsP detectors, and 100× 1.45 NA objective. |